Investment
Features
FeesSafety
Academy
More
Pluang+

Lifecore shareholders question $6.28 per share deal as Ademi LLP probes fairness and board actions

Market News
28 Sep 2026
PRNewsWire
View Source
Bearish
Lifecore shareholders question $6.28 per share deal as Ademi LLP probes fairness and board actions

Lifecore shareholders are set to receive $6.28 per share in a $663.7 million acquisition by Webster Equity Partners. Ademi LLP is investigating whether this price fairly reflects Lifecore's value and future prospects, and is scrutinizing benefits to company insiders and restrictions that may block better offers. The law firm is also reviewing whether Lifecore's Board acted in shareholders' best interests during negotiations. Shareholders are encouraged to contact Ademi LLP to discuss their rights and the ongoing investigation.

The Lifecore Biomedical acquisition and shareholder investigation provide context for health-sector trading. For readers following health stocks, here is Pluang's market snapshot as of Sep 28, 2026 22:21 WIB: Among 100 priced US health stocks, 49 rose and 49 fell. Amphastar Pharmaceuticals Inc (AMPH) rose 3.44% to USD 27.03 with a typical hold time of 18 days, contrasting with Tilray Brands Inc (TLRY) which fell 3.27% to USD 4.00 and Adaptive Biotechnologies Corp (ADPT) down 2.99% at USD 28.55, with hold times of 30 and 36 days respectively.

More News

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.

Vertex Pharmaceuticals reported a 12% revenue increase to $3.33 billion in Q2, driven by its dominant cystic fibrosis treatments. UBS raised its price target from $585 to $615, reflecting confidence in Vertex's strong financials and growth potential....

Analyst Insights
Bullish
2 hours ago
Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock jumps 37.6% on booming AI demand and strong financials ahead of Q4 earnings.

Accenture's stock surged 37.6% recently, driven by rising demand for AI services and new AI-focused offerings. The company outpaced industry growth and secured 100 new clients for advanced AI projects in one quarter. An analyst raised the price targe...

Analyst Insights
Bullish
3 hours ago
SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.

SpaceX, trading near $148 per share with a market cap of about $1.95 trillion, is preparing for Starship's first orbital mission and the deployment of its first operational Starlink V3 satellites. This milestone is key for expanding Starlink's global...

Market News
Bullish
3 hours ago
Ethereum (ETH) price dips below $2,700 on Binance, signaling a key support break.

Ethereum (ETH) price dips below $2,700 on Binance, signaling a key support break.

Ethereum's price fell below the critical $2,700 level on Binance spot trading, reaching $2,696 as of 9:37 a.m. ET on September 28. This break is notable because $2,700 is a closely watched support level by traders. Despite this drop, ETH's price was ...

Market News
Bearish
4 hours ago
HBAR price jumps nearly 10% in hours, extending 24-hour gain to 39%, driven by short position liquidations.

HBAR price jumps nearly 10% in hours, extending 24-hour gain to 39%, driven by short position liquidations.

Hedera's cryptocurrency token HBAR surged 9.76% within four hours, reaching $0.1302 on September 28, and extended its 24-hour gain to 39.20%. This price increase was accompanied by significant liquidations totaling $310,000, with more short positions...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App